Your browser doesn't support javascript.
loading
potential benefits of genetic testing in breast and ovarian cancer
Saudi Medical Journal. 1999; 20 (9): 663-670
in English | IMEMR | ID: emr-114925
ABSTRACT
This article reviews some of the recent molecular aspects of breast/ovarian tumorigenesis, addresses the application of BRCA1 and BRCA2 mutations as predictory markers, and discusses the benefits and limitations of the approach of molecular testing of the malignancy. The efficacy and controversy around the option of prophylactic surgery for affected women is also discussed. Apparently, the most significant advantage of genetic testing is the increased awareness of women, of high-risk families and carriers of BRCA1 and/or BRCA2 mutations, with the importance of periodic medical examination. Analysis of some recent data of breast/ovarian cancers among the female population of Saudi Arabia shows low onset age, low frequency and diagnosis at late stages of malignancy. The potential of molecular testing for diagnostic and counselling purposes in breast/ovarian cancers in this community is presented
Subject(s)
Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Ovarian Neoplasms / Genetic Techniques / Review / Genes, BRCA1 / Molecular Biology Limits: Female / Humans / Male Language: English Journal: Saudi Med. J. Year: 1999

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Ovarian Neoplasms / Genetic Techniques / Review / Genes, BRCA1 / Molecular Biology Limits: Female / Humans / Male Language: English Journal: Saudi Med. J. Year: 1999